BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 30475428)

  • 1. Pharmacokinetics of plasma infusion in congenital thrombotic thrombocytopenic purpura.
    Taylor A; Vendramin C; Oosterholt S; Della Pasqua O; Scully M
    J Thromb Haemost; 2019 Jan; 17(1):88-98. PubMed ID: 30475428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombotic thrombocytopenic purpura: pathogenesis, diagnosis and potential novel therapeutics.
    Saha M; McDaniel JK; Zheng XL
    J Thromb Haemost; 2017 Oct; 15(10):1889-1900. PubMed ID: 28662310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet rescue by macrophage depletion in obese ADAMTS-13-deficient mice at risk of thrombotic thrombocytopenic purpura.
    Geys L; Roose E; Scroyen I; Rottensteiner H; Tersteeg C; Hoylaerts MF; Vanhoorelbeke K; Lijnen HR
    J Thromb Haemost; 2018 Jan; 16(1):150-163. PubMed ID: 29121438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant ADAMTS-13: first-in-human pharmacokinetics and safety in congenital thrombotic thrombocytopenic purpura.
    Scully M; Knöbl P; Kentouche K; Rice L; Windyga J; Schneppenheim R; Kremer Hovinga JA; Kajiwara M; Fujimura Y; Maggiore C; Doralt J; Hibbard C; Martell L; Ewenstein B
    Blood; 2017 Nov; 130(19):2055-2063. PubMed ID: 28912376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical assessment of a new recombinant ADAMTS-13 drug product (BAX930) for the treatment of thrombotic thrombocytopenic purpura.
    Kopić A; Benamara K; Piskernik C; Plaimauer B; Horling F; Höbarth G; Ruthsatz T; Dietrich B; Muchitsch EM; Scheiflinger F; Turecek M; Höllriegl W
    J Thromb Haemost; 2016 Jul; 14(7):1410-9. PubMed ID: 27371116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism underlying severe deficiency of plasma ADAMTS-13 activity in immune thrombotic thrombocytopenic purpura.
    Zheng XL
    J Thromb Haemost; 2024 May; 22(5):1358-1365. PubMed ID: 38360215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. External validation of the PLASMIC score: a clinical prediction tool for thrombotic thrombocytopenic purpura diagnosis and treatment.
    Li A; Khalighi PR; Wu Q; Garcia DA
    J Thromb Haemost; 2018 Jan; 16(1):164-169. PubMed ID: 29064619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of diagnostic delay in congenital thrombotic thrombocytopenic purpura.
    Ferrari B; Cairo A; Pagliari MT; Mancini I; Arcudi S; Peyvandi F
    J Thromb Haemost; 2019 Apr; 17(4):666-669. PubMed ID: 30762934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant ADAMTS13 in Congenital Thrombotic Thrombocytopenic Purpura.
    Scully M; Antun A; Cataland SR; Coppo P; Dossier C; Biebuyck N; Hassenpflug WA; Kentouche K; Knöbl P; Kremer Hovinga JA; López-Fernández MF; Matsumoto M; Ortel TL; Windyga J; Bhattacharya I; Cronin M; Li H; Mellgård B; Patel M; Patwari P; Xiao S; Zhang P; Wang LT;
    N Engl J Med; 2024 May; 390(17):1584-1596. PubMed ID: 38692292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted ADAMTS-13 replacement therapy for thrombotic thrombocytopenic purpura.
    Moroniti JJ; Vrbensky JR; Nazy I; Arnold DM
    J Thromb Haemost; 2024 Apr; 22(4):896-904. PubMed ID: 38142844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The D173G mutation in ADAMTS-13 causes a severe form of congenital thrombotic thrombocytopenic purpura. A clinical, biochemical and in silico study.
    Lancellotti S; Peyvandi F; Pagliari MT; Cairo A; Abdel-Azeim S; Chermak E; Lazzareschi I; Mastrangelo S; Cavallo L; Oliva R; De Cristofaro R
    Thromb Haemost; 2016 Jan; 115(1):51-62. PubMed ID: 26272487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High prevalence of hereditary thrombotic thrombocytopenic purpura in central Norway: from clinical observation to evidence.
    von Krogh AS; Quist-Paulsen P; Waage A; Langseth ØO; Thorstensen K; Brudevold R; Tjønnfjord GE; Largiadèr CR; Lämmle B; Kremer Hovinga JA
    J Thromb Haemost; 2016 Jan; 14(1):73-82. PubMed ID: 26566785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unfolding the pathophysiology of congenital thrombotic thrombocytopenic purpura in pregnancy: lessons from a cluster of familial cases.
    Miodownik S; Pikovsky O; Erez O; Kezerle Y; Lavon O; Rabinovich A
    Am J Obstet Gynecol; 2021 Aug; 225(2):177.e1-177.e15. PubMed ID: 33621545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of relapse in patients with acquired thrombotic thrombocytopenic purpura undergoing elective surgery: a case series.
    Arcudi S; Ferrari B; Pontiggia S; Tufano A; Artoni A; Mancini I; Peyvandi F
    J Thromb Haemost; 2019 Mar; 17(3):492-498. PubMed ID: 30629316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amplified endogenous plasmin activity resolves acute thrombotic thrombocytopenic purpura in mice.
    Tersteeg C; Joly BS; Gils A; Lijnen R; Deckmyn H; Declerck PJ; Plaimauer B; Coppo P; Veyradier A; Maas C; De Meyer SF; Vanhoorelbeke K
    J Thromb Haemost; 2017 Dec; 15(12):2432-2442. PubMed ID: 28981198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of obstetrical thrombotic thrombocytopenic purpura in a retrospective study within thrombocytopenic pregnant women. A difficult diagnosis and a treatable disease.
    Delmas Y; Helou S; Chabanier P; Ryman A; Pelluard F; Carles D; Boisseau P; Veyradier A; Horovitz J; Coppo P; Combe C
    BMC Pregnancy Childbirth; 2015 Jun; 15():137. PubMed ID: 26081109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of clinical and laboratory characteristics in 42 patients with thrombotic thrombocytopenic purpura from a single center in China.
    Deng MY; Zhang GS; Zhang Y; Xiao H; Dai CW; Xu YX; Zheng WL; Peng HL; Shen JK
    Transfus Apher Sci; 2013 Dec; 49(3):447-52. PubMed ID: 23973730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of the ADAMTS-13 missense mutation R1060W in late onset adult thrombotic thrombocytopenic purpura.
    Camilleri RS; Cohen H; Mackie IJ; Scully M; Starke RD; Crawley JT; Lane DA; Machin SJ
    J Thromb Haemost; 2008 Feb; 6(2):331-8. PubMed ID: 18031293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombotic thrombocytopenic purpura.
    Lämmle B; Kremer Hovinga JA; Alberio L
    J Thromb Haemost; 2005 Aug; 3(8):1663-75. PubMed ID: 16102032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ADAMTS-13 may not predict disease or outcome in patients with Thrombotic Thrombocytopenic Purpura.
    Rock G; Clark WF; Anderson D; Benny B; Sutton D; Leblond P; Sternbach M; Sontrop J;
    Thromb Res; 2013 Apr; 131(4):308-12. PubMed ID: 23411128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.